Contáctenos

Información de Contacto

TEKNOVAS 
Parque Tecnológico de Bizkaia, Edificio 804
48160 - Derio (Bizkaia)
Tel.: +34 94 478 11 81
Fax: +34 94 478 07 70
E-mail: comercial@teknovas.com
Teknovas Sede Navarra 
C/ Comunidad de la Rioja nº5
31010 - Barañain (Navarra)
Tel.: +34 948 25 99 05
Fax: +34 948 25 99 07
E-mail: nekane.dominguez@teknovas.com
 

* Campos Requeridos

Para ver precios, disponibilidad y usar comparativas tiene que iniciar sesión o darse de alta

Leukopak, producto fresco de leucaféresis humana obtenido de sangre periférica normal, >2.5 billon cels. (LONZA)

Leukopak, producto fresco de leucaféresis humana obtenido de sangre periférica normal, >2.5 billon cels.

  • 1 Ud.
  • -
  • Disponibilidad:
    • Cod. Prov: 3P-105A
    • -
    • Ref. Teknovas: K33P-105A
    • -
    • Marca: LONZA
Fresh human leukopheresis product collected from normal peripheral blood, containing ≥ 2.5 billion cells
Tiene que Iniciar sesión o Darse de alta para ver los precios de los productos
Solicitar

Disponibilidad: Entrega inmediata

Descripción

Descripción & Documentación

Leukopaks are highly-enriched leukapheresis-derived products obtained from an IRB-approved collection facility. Leukopaks contain higher concentrations of mononuclear cells, B cells, T cells, stem/progenitor cells, dendritic cells, and other cell types as compared to standard venipuncture collection methods or buffy coat products.

Leukapheresis is performed using the Spectra Optia® Apheresis System with healthy, consented donors following IRB-approved protocols. MNC rich cells are continuously collected from 2-2.5 donor blood volumes into a sterile bag using ACD-A as an anticoagulant. Approximately 120mL of autologous plasma is automatically collected directly into the cell pool following leukapheresis.

Following collection, a total nucleated cell count is determined using AO/PI. A defined quantity of 2.5 billion apheresed cells (including a target overfill) is transferred into sterile containers. The total volume and concentration of the supplied cells will vary. Based on this count, the product is filled to deliver not less than 2.5 billion cells at release. On occasion (<10% of the time) the minimum number of cells to achieve the cell quantity is not achieved.

Leukapheresed TNC products typically contain up to 50% T cells, 20% monocytes, 10% B cells, and 10% NK cells, 3% granulocytes, and 3 % hematocrit. Actual percentages will vary from donor to donor. Manufactured by AllCells® Additional shipping charges apply for fresh, human origin products

    • Referencia:
    • K33P-105A
    • Especificaciones:
    • 1 bag containing ≥ 2.5 billion fresh cells
    • Categoría de Producto:
    • Células primarias
    • Disponibilidad:
    • Disponible bajo pedido
    • Tipo Celular:
    • Sanguíneas
    • Aplicaciones:
    • Bioprocesos, Cultivo celular
    • Especie/Huesped:
    • Humano